Analyst Ratings for 10X Genomics (TXG) [Neutrals]
TXG Rating Summary
TXG Price Target Summary
- Highest: $65.00 (JPMorgan)
- Lowest: $30.00 (Goldman Sachs)
- Average: $53.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$53.75 (+91.3%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
Avg. $ Target:
$53.75 (+91.3%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/12/2023 | BofA Securities | Derik de Bruin | Upgrade | Neutral (Underperform) |
54.00 (36.00) |
48.14 (28.09) |
-41.65% | Details |
| 2/2/2023 | UBS » Updated 2/21/2024 |
John Sourbeer | New Coverage | Neutral (N/A) |
52.00 (44.00) |
47.59 (28.09) |
-40.97% | Details |
 |
||||||||
